Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research report report published on Tuesday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Up 0.7 %

RVP stock opened at $0.75 on Tuesday. The firm has a 50-day moving average price of $0.79 and a 200-day moving average price of $0.75. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.23. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $22.30 million, a P/E ratio of -1.38 and a beta of 2.08.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. Wealthfront Advisers LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned about 8.46% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.